Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myeloproliferative Disorders × Diet, Mediterranean × 90 days × Clear all

Sponsor

Conditions

Smoldering Multiple Myeloma 1 Polycystic Ovary Syndrome 1 Neoplasms 1 Multiple Myeloma 1 Motor Activity 1 Monoclonal Gammopathy of Undetermined Significance 1 Intermittent Fasting 1 Cardiovascular Diseases 1 Breast Neoplasms 1

Interventions

Specimen Handling 11 fludarabine 10 Whole-Body Irradiation 8 Cyclophosphamide 8 Biopsy 8 Azacitidine 8 ruxolitinib 7 fludarabine phosphate 7 Mycophenolic Acid 7 venetoclax 6 Busulfan 6 Tacrolimus 5 decitabine and cedazuridine drug combination 4 Stem Cell Transplantation 4 Melphalan 4 Granulocyte Colony-Stimulating Factor 4 Thiotepa 3 Sirolimus 3 Peripheral Blood Stem Cell Transplantation 3 Injections 3 Cytarabine 3 Cyclosporins 3 Blood Specimen Collection 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 nilotinib 2 fedratinib 2 asciminib 2 X-Rays 2 Therapeutics 2 Liposomes 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡